Hemispherx BioPharma (HEB)

[Norm]

Over 25% of offering already sold. I think that it is safe to assume that they have sold more since the 1st of October also.

THE OFFERING


Offering Price, Shares, and Proceeds: Variable at-the-market pricing, with aggregate gross proceeds of up to $75.0 million. Up to 40,000,000 shares of common stock have been approved and allocated to the offering. As of October 1, 2012, 10,919,700 of these shares have been sold.
offering that may be made from time to time through our agent, Maxim
Manner of Offering: “At-the-market” .


**I am hoping that there next "time to time" selling will be after panel lol**